Exhibit 10.2
EXCHANGE AGREEMENT
THIS EXCHANGE AGREEMENT
(this “Agreement”) is dated as of March 20, 2017, between Authentidate Holding Corp., a Delaware corporation
(the “Company”) and the holder identified on the signature pages hereto (the “Holder”).
Recitals
WHEREAS, the Holders beneficially
owns and holds 28,000 shares of the Company’s Series B Preferred Stock, par value $0.10 per share; and
WHEREAS, pursuant
to the terms and conditions of this Agreement, the Company hereby offers to the Holder shares of a newly created class of convertible
preferred stock (the “Series E Preferred Stock”) and the Holder wishes to acquire shares of Series E Preferred
Stock in exchange for the surrender and cancellation of all of the shares of Series B Preferred Stock currently held by the Holder
upon the terms and conditions set forth herein in reliance on the exemption from registration provided by Section 3(a)(9) of the
Securities Act of 1933, as amended.
NOW, THEREFORE,
in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby
agreed and acknowledged, the parties hereto hereby agree as follows:
1. Defined Terms.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein
have the meanings given to such terms in the Series E Designation and (b) the following terms have the meanings set forth
in this Section 1:
“Affiliate”
of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect
common control with such specified Person. For the purposes of this definition, “control”, when used with
respect to any specified Person, means the power to direct the management and policies of such Person, directly or indirectly,
whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled”
have meanings correlative to the foregoing.
“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.
“Closing Date”
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto,
and all conditions precedent to: (i) the Holders’ obligations to surrender the Series B Preferred Stock and (ii) the
Company’s obligations to deliver the Series E Preferred Stock have been satisfied or waived.
“Commission”
means the United States Securities and Exchange Commission.
“Common Stock”
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.
“Conversion
Price” shall have the meaning ascribed to such term in the Series E Designation.
“Conversion
Shares” means the shares of Common Stock issuable upon the conversion of the shares of Series E Preferred Stock.
“Encumbrances”
shall mean any security or other property interest or right, claim, lien, pledge, option, charge, security interest, contingent
or conditional sale, or other title claim or retention agreement interest or other right or claim of third parties, whether perfected
or not perfected, voluntarily incurred or arising by operation of law, and including any agreement (other than this Agreement)
to grant or submit to any of the foregoing in the future.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
“Required
Approvals” shall have the meaning ascribed to such term in Section 4(d).
“Required
Minimum” means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable
in the future pursuant to the shares of Series E Preferred Stock to be issued under this Agreement, ignoring any conversion or
exercise limits set forth therein.
“Securities”
means the Series E Preferred Stock and the Conversion Shares.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Series B
Preferred Stock” means the shares of Series B Convertible Preferred Stock, par value $0.10 per share, with such preferences,
rights and other terms and conditions as is set forth in that certain Certificate of Designations, Preferences and Rights and Number
of Shares of Series B Convertible Preferred Stock originally filed by the Company with the Secretary of State of the State of Delaware
on October 5, 1999 and as has been amended to date.
“Series E
Preferred Stock” means the shares of Series E Convertible Preferred Stock, par value $0.10 per share, with such preferences,
rights and other terms and conditions as is set forth in the Series E Designation.
“Series E
Designation” means the Certificate of Designations, Preferences and Rights and Number of Shares of Series E Convertible
Preferred Stock filed by the Company with the Secretary of State of the State of Delaware on or before the Closing Date. The form
of Series E Designation to be filed with the Secretary of State of the State of Delaware is attached as Exhibit A to this Agreement.
“Trading Day”
means a day on which the principal Trading Market is open for trading.
“Trading Market”
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:
the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange,
or any tier of the OTC Markets Inc. (or any successors to any of the foregoing).
“Transaction
Documents” means this Agreement, the Series E Designation, all exhibits and schedules thereto and hereto and any other
documents or agreements executed in connection with the transactions contemplated hereunder.
2. Securities Exchange.
2.1 Exchange
and Closing.
(a) Upon the following
terms and subject to the conditions contained herein, Holder agrees to acquire from the Company the number of shares of Series
E Preferred Stock set forth on the Holder’s signature page to this Agreement in exchange for and in consideration of all
of such Holder’s rights, title and interest in and to the 28,000 shares of Series B Preferred Stock owned by the Holder.
In accordance with the terms and conditions of this Agreement, Holder shall deliver and surrender to the Company at its principal
offices for cancellation certificates representing all of the shares of Series B Preferred Stock owned by Holder, free and clear
of any liens, claims, charges, security interest or other legal or equitable Encumbrances in exchange for a certificate representing
such number of shares of Series E Preferred Stock set forth on the Holder’s signature page to this Agreement. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company’s counsel
or such other location and on such Business Day as the parties shall mutually agree.
(b) Assuming the
accuracy of the representations and warranties of the Company and the Holder set forth in Sections 2 and 3, respectively, of this
Agreement, the parties acknowledge and agree that the purpose of such representations and warranties is, among other things, to
ensure that the exchange transaction contemplated hereby qualifies as an exchange of securities under Section 3(a)(9) of the Securities
Act.
(c) In the event
Holder has lost his, her or its physical certificate(s) representing its shares of Series B Preferred Stock, or such certificate(s)
were lost, stolen or destroyed, Holder shall, instead of returning such physical certificate(s), execute and deliver to the Company
an affidavit of loss and indemnification undertaking (in a form acceptable to the Company) with respect to such shares of Series
B Preferred Stock and in which instrument the Holder acknowledges that the shares of Series B Preferred Stock are cancelled in
all respect in consideration of the Company’s issuance of the shares of Series E Preferred Stock hereunder.
2.2 Deliveries.
(a) On or prior to the Closing Date (except as otherwise provided
below), the Company shall deliver or cause to be delivered to Holder the following: (i) this Agreement duly executed by the
Company; (ii) physical certificate representing the shares of Series Preferred Stock acquired by the Holder hereunder and
registered in the name of Holder (such original certificate may be delivered within three Trading Days following Closing
Date); and (iii) such other documents relating to the transactions contemplated by this Agreement as the Holder or its
counsel may reasonably request.
(b) On
or prior to the Closing Date, Holder shall deliver or cause to be delivered to the Company, as applicable, the following: (i)
this Agreement duly executed by Holder; (ii) the Holder’s certificates representing shares of Series B Preferred Stock (or
an affidavit of loss and indemnity undertaking with respect thereto, in a form reasonably acceptable to the Company); and (iii)
such other documents relating to the transactions contemplated by this Agreement as the Company or its counsel may reasonably
request.
2.3 Closing Conditions.
(a)
The obligations of the Company hereunder in connection with the Closing are subject to the
satisfaction, or waiver by the Company, of the following conditions: (i) the accuracy in all material respects on the Closing
Date of the representations and warranties of the Holder contained herein (unless as of a specific date therein in which case
they shall be accurate as of such date); (ii) all obligations, covenants and agreements of the Holder required to be
performed at or prior to the Closing Date shall have been performed; (iii) the delivery by the Holder of the items set forth
in Section 2.2(b) of this Agreement; and (iv) the Company shall have received any Required Approvals necessary to
conduct the Closing.
(b) The obligations
of the Holder hereunder in connection with the Closing are subject to the satisfaction, or waiver by the Holder, of the following
conditions: (i) the accuracy in all material respects when made and on the Closing Date of the representations and warranties of
the Company contained herein (unless as of a specific date therein); (ii) all obligations, covenants and agreements of the Company
required to be performed at or prior to the Closing Date shall have been performed; and (iii) the delivery by the Company of the
items set forth in Section 2.2(a) of this Agreement.
(c) The obligations
of the parties hereunder are subject to the execution by the Company and an entity affiliated with the Holder, of a definitive
agreement to exchange an aggregate principal amount of $950,000 of convertible notes held by such Affiliate for a new convertible
note upon the terms and conditions described in such definitive agreement.
2.4 Status
of Series B Preferred Stock. At Closing, the shares of Series E Preferred Stock issued in exchange for surrender and cancellation
of the shares of Series B Preferred Stock shall be deemed the full and final consideration for the cancellation of such shares
of Series B Preferred Stock. On the Closing Date, each holder of record of shares of Series B Preferred Stock shall be deemed to
be the holder of record of the shares of Series E Preferred Stock issuable to such Holder hereunder, notwithstanding that certificates
representing such shares of Series E Preferred Stock shall not then be actually delivered to such Holder. From and after the Closing
Date, all of the shares of Series B Preferred Stock required to be delivered for exchange under this Agreement shall be deemed
to have been retired and cancelled in all respects, all rights of the Holder of such shares shall cease and terminate with respect
to such shares of Series B Preferred Stock except that such shares of Series B Preferred Stock shall solely represent the right
to receive the applicable number of shares of Series E Preferred Stock issuable in consideration of the surrender of the certificates
representing shares of Series B Preferred Stock. From and after the Closing, the shares of Series B Preferred Stock surrendered
for exchange shall not thereafter be transferred on the books of the Company or be deemed to be outstanding for any purpose whatsoever
and shall return to the status of authorized but unissued shares of preferred stock of the Company. The Company shall thereafter
be authorized to take any and all action it determines may be reasonably necessary to effect such cancellation of the shares of
Series B Preferred Stock.
3. Representations,
Warranties and Covenants of Holder. Holder hereby makes the following representations and warranties to
the Company, and covenants for the benefit of the Company.
(a) Due Organization
and Authorization; Binding Agreement. Holder is duly organized, validly existing and in good standing under the laws of the
jurisdiction of its organization. Holder has full right, power and authority to execute and deliver this Agreement and to consummate
the transactions contemplated hereby. This Agreement has been duly and validly authorized, executed and delivered by Holder and
(assuming due authorization, execution and delivery by the Company) constitutes the valid and binding obligation of Holder enforceable
against Holder in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium and other similar laws relating to or affecting creditors’ rights generally, and general equitable principles
(whether considered in a proceeding in equity or at law). No consent, approval, authorization
or order of any person, entity, court, administrative agency or governmental authority is required for the execution, delivery
or performance of this Agreement by the Holder.
(b) No Conflicts.
The execution, delivery and performance of this Agreement by the Holder and the consummation by the Holder of the transactions
contemplated hereby do not and will not: (i) conflict with, or constitute a default (or an event which with notice or lapse of
time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which
the Holder is a party or by which the Holder’s properties or assets are bound; or (ii) result in a violation of any federal,
state, local or foreign statute, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations)
applicable to the Holder or by which any property or asset of the Holder are bound or affected, except, in each case, for such
conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the
aggregate, materially and adversely affect the Holder’s ability to perform its obligations under this Agreement.
(c) Holder Status.
At the time Holder was offered the Series E Preferred Stock, it was, and as of the date hereof it is, and on each date on which
it converts shares of Series E Preferred Stock it will be either: (i) an “accredited investor” as defined in Rule 501(a)
under the Securities Act; or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities
Act. Holder is not required to be registered as a broker-dealer under Section 15 of the Exchange Act. Holder has sufficient knowledge
and experience in financial matters as to be capable of evaluating the risks and merits of the transaction contemplated hereby.
Holder is able to bear the economic risk of its investment in the Series E Preferred Stock for an indefinite period of time, is
able to afford a complete loss of such investment, and acknowledges that no public market exists for the Series E Preferred Stock
or the Conversion Shares and that there is no assurance that a public market will ever develop for such securities. Neither, the
Series E Preferred Stock nor the Conversion Shares have been registered under the Securities Act and, therefore, cannot be sold
unless subsequently registered under the Securities Act or an exemption from such registration is available.
(d) Information.
Holder has reviewed, or has had the opportunity to review, with the assistance of professional and legal advisors of its choosing,
all information (including all documents filed or furnished to the Commission by the Company) relating to the business, finances
and operations of the Company and materials relating to the exchange transaction which have been requested by such Holder. Such
Holder has been afforded the opportunity to ask questions of the Company and has had sufficient access to the Company necessary
for Holder to decide to exchange its Series B Preferred Stock for the Series E Preferred Stock in accordance with this Agreement.
Such Holder acknowledges that all of the documents filed by the Company with the Commission under Sections 13(a), 14(a) or 15(d)
of the Exchange Act, that have been posted on the XXXXX site maintained by the Commission are available to such Holder, and such
Holder has not relied on any statement of the Company not contained in such documents in connection with such Holder’s decision
to enter into this Agreement or any other Transaction Document and to consummate the transactions contemplated hereby.
(e) Certain Disqualification
Events. Neither the Holder, nor any director, executive officer, other member or officer of the Holder participating in the
transactions contemplated by this Agreement, any beneficial owner of 20% of more of the Holder’s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities
Act) connected with the Holder in any capacity at the time of sale (each a “Holder Covered Person”) is
subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act
(a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (3) (provided
that the foregoing exception shall not be available hereunder with respect to Rule 506(d)(2)(iv) for any Disqualification Event
of which the Company did not know as a result of the Holder’s failure to disclose such Disqualification Event to the Company).
Holder has exercised reasonable care to determine: (i) the identity of each person that is a Holder Covered Person; and (ii) whether
any Holder Covered Person is subject to a Disqualification Event.
(f) Own
Account. The Holder is and will be acquiring the Securities for the Holder’s own account, for investment purposes, and
not with a view to any resale or distribution in whole or in part, in violation of the Securities Act or any applicable securities
laws; provided, however, that by making the representations herein, the Holder does not agree to hold such Securities
for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with federal
and state securities laws applicable to such disposition.
(g) Restricted
Securities. The Holder understands that the Securities purchased hereunder, including the Conversion Shares, are “restricted
securities,” as that term is defined in the Securities Act and the rules thereunder, have not been registered under the Securities
Act, and that none of the Securities can be sold or transferred unless they are first registered under the Securities Act and such
state and other securities laws as may be applicable or an exemption from registration under the Securities Act is available (and
then the Securities may be sold or transferred only in compliance with such exemption and all applicable state and other securities
laws). Holder acknowledges that all certificates representing any of the shares of Series E Preferred Stock and the Conversion
Shares will bear a restrictive legend in a form as set forth below and hereby consents to the transfer agent for the Company’s
Common Stock making a notation on its records to implement the restrictions on transfer described herein. Holder further
understands that except as provided in the Transaction Documents: (i) the Securities have not been and are not being registered
under the Securities Act or any state securities laws, must be held indefinitely and may not be offered for sale, sold, assigned
or transferred unless: (A) subsequently registered thereunder; (B) Holder shall have delivered to the Company an opinion of counsel,
in a generally acceptable form, to the effect that such Securities to be sold, assigned or transferred may be sold, assigned or
transferred pursuant to an exemption from such registration; or (C) Holder provides the Company with reasonable assurance that
such Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the Securities Act (or
a successor rule thereto) (collectively, “Rule 144”); (ii) any sale of the Securities made in reliance
on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of
the Securities under circumstances in which the seller (or the Person (through whom the sale is made) may be deemed to be an underwriter
(as that term is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the
rules and regulations of the Commission thereunder; and (iii) except as set forth in the Transaction Documents, neither the Company
nor any other Person is under any obligation to register the Securities under the Securities Act or any state securities laws or
to comply with the terms and conditions of any exemption thereunder.
(h) Reliance
on Representations. Holder understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon
the truth and accuracy of, and Holder’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of Holder set forth herein in order to determine the availability of such exemptions and the eligibility of Holder
to acquire the Securities. The Holder undertakes to immediately notify the Company of any change in any statement or other information
relating to the Holder which takes place prior to the Closing time. No Person has made any written or oral representations to the
Holder that: (i) any Person will resell or repurchase the shares of Series E Preferred Stock or the Conversion Shares or (ii) as
to the future price or value of the shares of Common Stock of the Company.
(i) No Brokers.
The Holder has not employed any broker or finder or incurred any liability for any brokerage or investment banking fees, commissions,
finders’ structuring fees, financial advisory fees or other similar fees in connection with any of the transactions contemplated
by this Agreement.
(j) No General
Solicitation. The Holder acknowledges that the Securities were not offered to the Holder by means of any form of general or
public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including: (i) any advertisement,
article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast over television or
radio; or (ii) any seminar or meeting to which the Holder was invited by any of the foregoing means of communications.
(k) Representations
Regarding Series B Preferred Stock. The Holder owns and holds, beneficially and of record, the entire right, title, and interest
in and to the shares of Series B Preferred Stock held by it, free and clear of any and all pledges, liens, security interests,
mortgage, claims, charges, restrictions, options, title defects or Encumbrances other than restrictions under the Securities Act
and other applicable federal and state securities laws. Holder has not, in whole or in part, (x) assigned, transferred, hypothecated,
pledged or otherwise disposed of the shares of Series B Preferred Stock or its rights in such shares of Series B Preferred Stock,
or (y) given any person or entity any transfer order, power of attorney or other authority of any nature whatsoever with respect
to such shares of Series B Preferred Stock which would limit the Holder’s power to transfer the shares of Series B Preferred
Stock hereunder. Holder has the sole and unencumbered right and power to transfer and dispose of the shares of Series B Preferred
Stock, and such shares of Series B Preferred Stock are not subject to any agreement, arrangement or restriction with respect to
the voting or transfer of the shares of Series B Preferred Stock, except for this Agreement. No additional consideration for any
purpose shall be due to Holder at Closing, with respect to the shares of Series B Preferred Stock, other than the shares of Series
E Preferred Stock. Upon delivery of the shares of Series B Preferred Stock to the Company for cancellation (as contemplated by
this Agreement), the Company will receive good and marketable title to the shares of Series B Preferred Stock, free and clear of
all pledges, liens, security interests, mortgage, claims, charges, restrictions, options, title defects or Encumbrances. The shares
of Series B Preferred Stock being surrendered by it for cancellation pursuant to this Agreement represent all of the shares of
Series B Preferred Stock of the Company in which Holder owns any legal or beneficial interest.
(l) No Representations.
No person or entity, other than the Company, has been authorized to give any information or to make any representation on behalf
of the Company in connection with the offering of Securities, and if given or made, such information or representations have not
been relied upon by the Holder as having been made or authorized by the Company. The only representations and warranties
made by the Company in connection with the offering of Securities are those contained in this Agreement, and the only information
made available by the Company in connection with the offering of Securities is contained in this Agreement.
(m) No
Legal, Tax or Investment Advice. Holder understands that the tax consequences of the transactions contemplated
by this Agreement are complex, and accordingly Holder represents and warrants that it understands that nothing in this Agreement
or any other materials presented by or on behalf of the Company to him, her or it in connection with this Agreement and the transactions
contemplated herein, constitutes legal, tax or investment advice. Holder has consulted such legal, tax and investment
advisors as he, she or it, in his, her or its sole discretion, has deemed necessary or appropriate in the circumstances.
Holder is not relying on the Company or any of its respective affiliates or agents, including its counsel and accountants, for
any tax advice regarding the tax consequences of the transactions contemplated by this Agreement.
(n) No
Governmental Review. Such Holder understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement in connection with the transactions contemplated by this Agreement
or the fairness or suitability of the investment in the Series E Preferred Stock nor have such authorities passed upon or endorsed
the merits of the Series E Preferred Stock.
4. Representations, Warranties and Covenants of the Company. The
Company represents and warrants to the Holder, and covenants for the benefit of the Holder, as follows:
(a) Due
Organization. The Company has been duly incorporated and is validly existing and in good standing under the laws of the state
of Delaware, with full corporate power and authority to own, lease and operate its properties and to conduct its business as currently
conducted. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in
each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except
where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document; (ii) a material
adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and
the Subsidiaries, taken as a whole; or (iii) a material adverse effect on the Company’s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing
or seeking to revoke, limit or curtail such power and authority or qualification.
(b) Due Authorization;
Binding Agreement; No Conflicts. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action
on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders
in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction
Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in
accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, subject to the Required Approvals and except: (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.
(c) Issuance of
Series E Preferred Stock. The issuance of the Series E Preferred Stock is duly authorized and, upon issuance in accordance
with the terms hereof, the shares of Series E Preferred Stock will be validly issued, fully paid and non-assessable. The shares
of Common Stock issuable upon conversion of the Series E Preferred Stock, when issued and delivered in accordance with the terms
of the Series E Designation, will be duly and validly issued, fully paid and non-assessable, free and clear of all Encumbrances,
other than restrictions on transfer under applicable state and federal securities laws.
(d) Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) those
that have previously been obtained; (ii) the filings required pursuant to the Exchange Act; (iii) the notice and/or application(s)
to each applicable Trading Market, if any, for the issuance and sale of the Securities and the listing of the Conversion Shares
for trading thereon in the time and manner required thereby; and (iv) such other filings with the Commission as may be required
under the Securities Act and such filings as are required to be made under applicable state securities laws (collectively, the
“Required Approvals”).
5. Other Agreements.
5.1 Transfer
Restrictions.
(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of
Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Holder,
the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably
acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect
that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer,
any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations
of a Holder under this Agreement.
(b) The Holders agree
to the imprinting, so long as is required by this Section 5.1, of a legend on any of the Securities substantially in the following
form:
[NEITHER] THIS SECURITY [NOR
THE SECURITIES INTO WHICH THIS SECURITY IS [EXERCISABLE] [CONVERTIBLE]] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
(c) Each Holder,
severally and not jointly with the other Holders, agrees with the Company that Holder will sell any Securities pursuant to either
the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a registration statement, they will be sold in compliance with the plan
of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 5.1 is predicated upon the Company’s reliance upon this understanding.
5.2 Reservation
of Securities. Subject to obtaining the Required Approvals, the Company shall maintain a reserve from its duly authorized shares
of Common Stock for issuance pursuant to the Transaction Documents in an amount no less than the Required Minimum. If, on any date,
the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum on such
date, then the Board of Directors shall use commercially reasonable efforts to amend the Company’s certificate of incorporation
to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time, as soon
as possible, including by calling a meeting of the Company’s shareholders for such purpose.
5.3 Fees and
Expenses. Each party hereto shall pay the fees and expenses of its advisors, counsel, accountants and other experts,
if any, and all other expenses, incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of this Agreement.
5.4 Waiver of Dividends. Effective
as of the Closing Date, the Holder hereby irrevocably waives any and all claims, demands, suits, actions, causes of action
and rights whatsoever at law or in equity, now existing or arising relating to any accrued and unpaid dividends on the shares of
Series B Preferred Stock. The Holder hereby acknowledges and agrees that it shall not commence or prosecute in any way,
or cause to be commenced or prosecuted, any action in any court relating to such accrued and unpaid dividends.
5.5 Piggyback
Registration Rights. Holder and the Company agree that the Holder shall be entitled to the registration rights with respect
to the Underlying Shares as set forth in this Section 5.5.
(a) Definition
of Registrable Securities. As used in this Section 5.5, the term “Registrable Security” means, as of any date of
determination, (a) all of the shares of Common Stock then issued and issuable upon conversion in full of the Series E Preferred
Stock (assuming on such date the shares of Series E Preferred Stock is converted in full without regard to any conversion limitations
therein), (b) any additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the
Series E Preferred Stock (in each case, without giving effect to any limitations on conversion set forth in the Series E Preferred
Stock), and (c) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or
similar event with respect to the foregoing; provided, however, that any such Registrable Securities shall cease to be Registrable
Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, registration statement
hereunder with respect thereto) for so long as (i) a registration statement with respect to the sale of such Registrable Securities
is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder
in accordance with such effective registration statement, (ii) such Registrable Securities have been previously sold in accordance
with Rule 144, or (iii) such securities become eligible for resale without volume or manner-of-sale restrictions and without current
public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable
to the Company’s transfer agent and the affected Holders (assuming that such securities and any securities issuable upon
exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no
time held by any Affiliate of the Company). The term “Registrable Securities” means any and all of the securities falling
within the foregoing definition of “Registrable Security.”
(b) Piggyback
Registration Rights. As used herein, a “Registration Statement” shall mean any registration statement filed by
the Company with the Commission under the Securities Act at any time or from time to time commencing on a date within one year
that any Underlying Shares may be issuable to the Holder and while any Registrable Securities remain outstanding; provided, however,
that a Registration Statement for the purposes hereof shall not include: (A) any registration statement (or amendment thereto)
filed by the Company which has not been declared effective on or before the date hereof; (B) any registration statement on Form
S-3 (or any successor form) filed by the Company for the purpose of effecting offers and sales of securities on a continuous or
delayed basis pursuant to Rule 415(a)(ix) or (x) under the Securities Act; (C) a registration relating to employee benefit plans
(whether effected on Form S-8 or its successor); or (D) a registration effected on Form S-4 (or its successor). If at any time
or from time to time while any Registrable Securities remain outstanding, the Company shall determine to register or shall be required
to register any of its Common Stock, whether or not for its own account, the Company shall:
(i) provide
to each Holder written notice thereof at least seven (7) days prior to the filing of the Registration Statement by the Company
in connection with such registration;
(ii) include
in such registration, and in any underwriting involved therein, all those Registrable Securities specified in a written request
by each Holder received by the Company within five (5) days after the Company mails the written notice referred to above. The Company
may withdraw the registration at any time. If a registration covered by this Section 5.5 is an underwritten registration on behalf
of the Company, and the underwriters advise the Company in writing that in their opinion the number of securities requested to
be included in such registration exceeds the number which can be sold in such offering without adversely affecting the marketability
of the offering, the Company shall include in such registration: (1) first, the securities the Company proposes to sell, (2) second,
the Registrable Securities and other securities requested to be included in such registration, pro rata among the selling Holders
and any other selling security holders on the basis of the number of Registrable Securities owned by each such Holder and other
selling security holders. The Holders’ right to have Registrable Securities included in the first registration statement
filed by the Company may be deferred to the second registration statement filed by the Company, which deferral may be continued
to the third or subsequent registration statement so long as the registration statements are pursuant to underwritten offerings
and the underwriter determines in good faith that marketing factors require exclusion of some or all of the Registrable Securities
held by the Holders, but such deferral shall be only to the extent of such required exclusion as determined by the underwriter;
and
(iii) if
the registration is an underwritten registration, each Holder of Registrable Securities shall enter into an underwriting agreement
in customary form with the underwriter and provide such information regarding Holder that the underwriter shall reasonably request
in connection with the preparation of the prospectus describing such offering, including completion of FINRA Questionnaires.
(c) Covenants
with Respect to Registration. In connection with the registration in which the Registrable Securities are included, the Company
and Holder covenant and agree as follows:
(i) The
foregoing registration rights shall be contingent on the Holders furnishing the Company with such appropriate information as the
Company shall reasonably request, including (A) such information regarding itself, the Registrable Securities held by it and the
intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect the registration
of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably
request. At least seven days prior to the first anticipated filing date of any Registration Statement, the Company shall notify
each Holder of the information the Company requires from such Holder if such Holder elects to have any of the Registrable Securities
included in the Registration Statement. A Holder shall provide such information to the Company at least two (2) Business Days prior
to the first anticipated filing date of such Registration Statement if it elects to have any of the Registrable Securities included
in the Registration Statement. Each Holder agrees to furnish to the Company a completed selling security holder questionnaire (a
“Questionnaire”) in the form provided to it by the Company not less than two Business Days prior to the filing date
of such Registration Statement. The Company shall not be required to include the Registrable Securities of a Holder in a Registration
Statement and shall not be required to pay any damages to such Holder who fails to furnish to the Company a fully completed Questionnaire
at least two Business Days prior to the filing date. The Company may require each selling Holder to furnish to the Company a certified
statement as to the number of shares of Common Stock beneficially owned by it and, if required by the Commission, the natural persons
thereof that have voting and dispositive control over its shares of Common Stock.
(ii) Each Holder,
by its acceptance of the Registrable Securities agrees to cooperate with the Company as reasonably requested by the Company in
connection with the preparation and filing of a Registration Statement hereunder, unless such Holder has notified the Company in
writing of its election to exclude all of its Registrable Securities from such Registration Statement. Each Holder agrees that,
upon receipt of any notice from the Company that it must suspend sales of Common Stock pursuant to the Registration Statement,
it will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable
Securities, until the Holder is advised by the Company that such dispositions may again be made.
(iii) Each
Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to
it in connection with sales of Registrable Securities pursuant to a Registration Statement.
(iv) The
Company shall indemnify each Holder of Registrable Securities to be sold pursuant to the registration statement and each person,
if any, who controls such Holder within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, against
all loss, claim, damage, expense or liability (including reasonable expenses reasonably incurred in investigating, preparing or
defending against any claim) to which any of them may become subject under the Securities Act, the Exchange Act or otherwise, arising
from such registration statement, except to the extent arising under paragraph (v) below.
(v) Each
Holder owning Registrable Securities to be sold pursuant to a registration statement, and their successors and assigns, shall severally,
and not jointly, indemnify the Company, its officers and directors and any underwriter, and each person, if any, who controls the
Company or such underwriter within the meaning of Section 15 of the Act or Section 20(a) of the Exchange Act, against all loss,
claim, damage or reasonable expense or liability (including expenses reasonably incurred in investigating, preparing or defending
against any claim) to which they may become subject under the Securities Act, the Exchange Act or otherwise, arising (A) from information
furnished by or on behalf of such Holder, or their successors or assigns, for inclusion in such registration statement, or (B)
as a result of use by the Holder of a registration statement that the Holder was advised to discontinue.
6. Miscellaneous.
6.1 Governing Law;
Consent to Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State
of Delaware, without regard to the conflicts of laws principles thereof. Each party hereto agrees that it shall bring any
action, proceeding, suit, demand, or claim with respect to any matter arising out of or related to this Agreement or the
transactions contained in or contemplated by this Agreement, exclusively in the Delaware Court of Chancery and any state
appellate court therefrom within the State of Delaware (unless the Delaware Court of Chancery shall decline to accept
jurisdiction over a particular matter, in which case, in any Delaware state or federal court within the State of Delaware)
(such courts, collectively, the “Delaware Courts”), and solely in connection with claims arising under
this Agreement or the transactions that are the subject of this Agreement (i) irrevocably submits to the exclusive
jurisdiction of the Delaware Courts, (ii) waives any objection to laying venue in any such action or proceeding in the
Delaware Courts, (iii) waives any objection that the Delaware Courts are an inconvenient forum or do not have jurisdiction
over either party hereto, (iv) agrees that service of process upon such party in any such action or proceeding shall be
effective if notice is given in accordance with Section 6.5 of this Agreement, although nothing contained in this
Agreement shall affect the right to serve process in any other manner permitted by law and (v) agrees not to seek a
transfer of venue on the basis that another forum is more convenient. Notwithstanding anything herein to the contrary, (A)
nothing in this Section 6.1 shall prohibit any party from seeking or obtaining orders for conservatory or interim
relief from any court of competent jurisdiction and (B) each party hereto agrees that any judgment issued by a Delaware Court
may be recognized, recorded, registered or enforced in any jurisdiction in the world and waives any and all objections or
defenses to the recognition, recording, registration or enforcement of such judgment in any such jurisdiction.
6.2 Confidentiality. The
Holder acknowledges and agrees that the existence of this Agreement and the information contained herein and in the Exhibits hereto
(collectively, “Confidential Information”) is of a confidential nature and shall not, without the prior
written consent of the Company, be disclosed by the Holder to any person or entity, other than the Holder’s personal financial
and legal advisors for the sole purpose of evaluating an investment in the Company, and that it shall not, without the prior written
consent of the Company, directly or indirectly, make any statements, public announcements or release to trade publications or the
press with respect to the subject matter of this Agreement. Notwithstanding the foregoing, the Holder may use or disclose
Confidential Information to the extent the Holder is required by law to disclose such Confidential Information, provided, however,
that prior to any such required disclosure, Holder shall give the Company reasonable advance notice of any such disclosure and
shall cooperate with the Company in protecting against any such disclosure and/or obtaining a protective order narrowing the scope
of such disclosure and/or use of the Confidential Information. The Holder further acknowledges and agrees that the information
contained herein and in the other documents relating to this transaction may be regarded as material non-public information under
United States federal securities laws, and that United States federal securities laws prohibit any person who has received material
non-public information relating to the Company from purchasing or selling securities of the Company, or from communicating such
information to any person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell
securities of the Company. Accordingly, until such time as any such non-public information has been adequately disseminated
to the public, the Holder shall not purchase or sell any securities of the Company, or communicate such information to any other
person.
6.3 Entire Agreement;
Amendment and Waivers. This Agreement constitutes the entire understanding and agreement of the parties with respect
to the subject matter hereof and supersedes all prior and/or contemporaneous oral or written proposals or agreements relating thereto
all of which are merged herein. This Agreement may not be amended or any provision hereof waived in whole or in part,
except by a written amendment signed by all of the parties hereto. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any
right hereunder in any manner impair the exercise of any such right.
6.4 Counterparts. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood
that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or
by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.
6.5 Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Trading Day; (b) the next Trading Day after the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day; (c) the second (2nd) Trading Day following the date
of mailing, if sent by U.S. nationally recognized overnight courier service; or (d) upon actual receipt by the party to whom
such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto.
6.6 Severability.
Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be
ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms
and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement
in any other jurisdiction.
6.7 Survival.
All representations and warranties made by the Company and each Holder will survive the execution of this Agreement and the Closing
until the first anniversary of the Closing Date, except for those representations and warranties which speak as of a specific date.
All covenants and other agreements set forth in this Agreement shall survive the Closing for the respective periods set forth therein
and if no such period is specified until the first anniversary of the Closing Date.
6.8 Specific
Performance; Enforcement. Each of the parties hereto recognizes and acknowledges that a breach by it of any covenants or agreements
contained in this Agreement will cause the other party to sustain damages for which it would not have an adequate remedy at law
for money damages, and therefore, each of the parties hereto agrees that in the event of any such breach the aggrieved party shall
be entitled to the remedy of specific performance of such covenants and agreements and injunctive and other equitable relief in
addition to any other remedy to which it may be entitled at law or in equity. The parties agree that they shall be entitled to
enforce specifically the terms and provisions of this Agreement in addition to any other remedy to which they may entitled at law
or in equity.
6.9
Assignment; Binding Effect; Benefits. This Agreement is not assignable without the written consent of each of
the other parties hereto. Subject to the foregoing, the provisions of this Agreement shall be binding upon and inure to the
benefit of the parties and their respective heirs, legal representatives, successors and permitted assigns. Except as
expressly stated elsewhere herein, nothing in this Agreement, express or implied, is intended or shall be construed to give
any person other than the parties or their respective successors or assigns any legal or equitable right, remedy or claim
under or in respect of any agreement or any provision contained herein.
6.10 Independent
Nature of Holders’ Obligations and Rights. The obligations of Holder under any Transaction Document are several and not
joint with the obligations of any other Holder, and no Holder shall be responsible in any way for the performance or non-performance
of the obligations of any other Holder under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Holders are in any way acting in concert or as a
group with respect to such obligations or the transactions contemplated by the Transaction Documents. Holder shall be entitled
to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out
of the other Transaction Documents, and it shall not be necessary for any other Holder to be joined as an additional party in any
proceeding for such purpose.
6.11 Independent
Representation. Each Holder expressly represents and warrants to the Company that (a) before executing this Agreement,
said Holder has fully informed himself or itself of the terms, contents, conditions and effects of this Agreement; (b) said
Holder has relied solely and completely upon his or its own judgment in executing this Agreement; (c) said Holder has had
the opportunity to seek the advice of his or its own counsel and advisors before executing this Agreement; (d) said Holder
has acted voluntarily and of his or its own free will in executing this Agreement; (e) said Holder is not acting under duress,
whether economic or physical, in executing this Agreement; (f) this Agreement is the result of arm’s length negotiations
conducted by and among the parties; and (g) said Holder acknowledges that the law firm of Xxxxxx & Xxxxxxxxx, LLP has
been retained by the Company to prepare this Agreement as legal counsel for the Company, that Xxxxxx & Poliakoff, LLP does
not represent any Holder in connection with the preparation or execution of this Agreement, that such firm has not given any legal,
investment or tax advice to any Holder regarding this Agreement, and that such Holder has not relied upon any legal advice except
as provided by its own attorneys. Xxxxxx & Xxxxxxxxx, LLP is expressly intended as a beneficiary of the representations and
warranties of the Holders contained in this Section 6.11.
6.12 Fees
and Expenses. Except as expressly set forth in this Agreement to the contrary, each party shall pay the fees and expenses of
its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement.
6.13
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated,
lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon
cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument,
but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.
6.14
Termination. If the Initial Closing has not been consummated on
or before March 15, 2017, this Agreement may be terminated (a) by the Holder (except where such Holder is in breach of this
Agreement or has failed to perform or satisfy any closing condition applicable to it), as to such Holder’s obligations
hereunder only, or (b) by the Company (except for any breach by it or failure to perform or satisfy any closing condition
applicable to it), by written notice to the other parties; provided, however, that such termination will not
affect the right of any non-breaching party to xxx or seek specific performance for any breach by any other party (or
parties).
6.15
Construction. The parties agree that each of them and/or their respective counsel have reviewed and
had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction
Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any
Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement. In this Agreement, unless the
context otherwise requires: (i) words of the masculine or neuter gender will include the masculine, neuter and/or feminine
gender, and words in the singular number or in the plural number will each include, as applicable, the singular number or the
plural number, (ii) reference to any Person includes such Person’s successors and assigns but, if applicable, only if
such successors and assigns are permitted by this Agreement, (iii) the words “include,” “includes”
and “including” when used herein shall be deemed in each case to be followed by the words
“without limitation,” (iv) reference to any law means such law as amended, modified codified or reenacted, in
whole or in part, and in effect from time to time, including rules and regulations promulgated thereunder, (v) except as
otherwise indicated, all references in this Agreement to the words “Section,” “Schedule” and
“Exhibit” are intended to refer to Sections, Schedules and Exhibits to this Agreement, (vi) the headings of the
Sections of this Agreement are for convenience only and in no way modify, interpret or construe the meaning of specific
provisions of this Agreement, (vi) the words “herein,” “hereto,” and “hereby” and other
words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any
particular Section or other subdivision of this Agreement, (vii) any reference herein to “dollars” or
“$” shall mean United States dollars, (viii) any reference herein to a Governmental Authority shall be deemed to
include reference to any successor thereto, and (ix) the specificity of any representation or warranty contained herein shall
not be deemed to limit the generality of any other representation or warranty contained herein.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, the Company
and each Holder has caused this Agreement to be executed on its behalf as of the date first written above.
AUTHENTIDATE HOLDING CORP. |
|
|
|
Address for Notice: |
|
|
|
0000 Xxxxxxxxxx Xxxxx |
|
|
|
Xxxxxxxxxxx, XX 00000 |
|
|
|
Attn: Chief Executive Officer |
|
|
|
|
|
|
|
Fax: |
Name: Xxxxx X. Xxxxxx |
|
|
Title: Chief Executive Officer |
|
|
|
|
|
With a copy to (which shall not constitute notice): |
|
|
|
|
|
Xxxxxx & Poliakoff, LLP |
|
|
00 Xxxxxxxx, 0xx Xxxxx |
|
|
Xxx Xxxx, XX 00000 |
|
|
Attn: Xxxxxxx X. Xxxxxxxxx |
|
|
Fax: 000-000-0000 |
|
|
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE PAGE FOR PURCHASER FOLLOWS]
[HOLDER SIGNATURE PAGES TO EXCHANGE AGREEMENT]
IN WITNESS WHEREOF, the undersigned have
caused this Exchange Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.
Name of Holder: |
|
|
|
|
|
Signature of Authorized Signatory of Holder: |
|
|
|
|
|
Name of Authorized Signatory: |
|
|
|
|
|
Title of Authorized Signatory: |
|
|
|
|
|
Email Address of Authorized Signatory: |
|
|
|
|
|
Facsimile Number of Authorized Signatory: |
|
|
|
|
|
Social Security or Tax I.D. Number: |
|
|
|
|
|
Address for Notices to Holder: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address for Delivery of certificated Securities for Holder (if not same as address for notices): |
|
|
|
|
|
|
|
|
|
|
|
Number of Shares of Series E Preferred Stock to be issued at
Closing: ________________
EXHIBIT A
CERTIFICATE OF DESIGNATIONS OF SERIES
E PREFERRED STOCK